NORTHEAST FINANCIAL CONSULTANTS INC – Abbott Laboratories Transaction History
NORTHEAST FINANCIAL CONSULTANTS INC portfolio value:
$539,000
portfolio value
NORTHEAST FINANCIAL CONSULTANTS INC quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -10.00% | -619 shares | -134K | $96.76 | 5.57K |
| Q2 2022 | share | Decrease | -3.63% | -233 shares | -87K | $108.65 | 6.19K |
| Q1 2022 | share | Increase | +4.40% | 271 shares | -106K | $118.36 | 6.42K |
| Q4 2021 | share | 0.00% | 0 shares | 139K | $141 | 6.15K | |
| Q3 2021 | share | 0.00% | 0 shares | 14K | $117.68 | 6.15K | |
| Q2 2021 | share | Increase | +0.46% | 28 shares | -21K | $115.05 | 6.15K |
| Q1 2021 | share | Increase | +14.91% | 795 shares | 150K | $118.49 | 6.12K |
| Q4 2020 | share | Increase | +0.47% | 25 shares | 7K | $107.81 | 5.33K |
| Q3 2020 | share | Increase | +0.28% | 15 shares | 93K | $106.81 | 5.30K |
| Q2 2020 | share | Decrease | -43.66% | -4.1K shares | -257K | $89.39 | 5.29K |
| Q1 2020 | share | Increase | +0.20% | 19 shares | -73K | $76.84 | 9.39K |
| Q4 2019 | share | 0.00% | 0 shares | 30K | $84.23 | 9.37K | |
| Q3 2019 | share | 0.00% | 0 shares | -4K | $80.81 | 9.37K | |
| Q2 2019 | share | 0.00% | 0 shares | 39K | $80.92 | 9.37K | |
| Q1 2019 | share | Increase | 0.00% | 9.37K shares | 749K | $76.6 | 9.37K |
| Q4 2018 | share | Decrease | -100.00% | -3.42K shares | -251K | $68.98 | 0 |
| Q3 2018 | share | Decrease | -19.02% | -805 shares | -7K | $69.69 | 3.42K |
| Q2 2018 | share | 0.00% | 0 shares | 5K | $57.68 | 4.23K | |
| Q1 2018 | share | Decrease | -4.19% | -185 shares | 1K | $56.4 | 4.23K |
| Q4 2017 | share | Increase | +4.37% | 185 shares | 26K | $53.46 | 4.41K |
| Q3 2017 | share | 0.00% | 0 shares | 20K | $49.74 | 4.23K | |
| Q2 2017 | share | Increase | 0.00% | 4.23K shares | 206K | $45.07 | 4.23K |